ALZHEIMER'S DISEASE

There are 8 studies

ALZHEIMER'S DISEASE STUDY

Fairfax

Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming?

Is someone you care for with Alzheimer’s dementia exhibiting excessive motor activity, verbal and/or physical aggression?
If so, they may qualify for the ASPECT™ clinical research study. The purpose of this study is to evaluate the safety and effectiveness of an investigational drug for agitation associated with Alzheimer’s dementia.

To be eligible for this study, a potential participant must:
✓ Be between the ages of 50 and 90
✓ Have a diagnosis of probable Alzheimer’s dementia
✓ Have moderate-to-severe agitation that interferes with their daily life
✓ Have a reliable caregiver who spends a minimum of 2 hours per day, 4 days per week with them and is willing and able to comply with all study procedures

Other eligibility criteria may apply.
The image depicted contains models and is being used for illustrative purposes only.

Those who qualify will receive study-required medical care and study drug at no cost.
Health insurance is not required.

For more information visit or call:
Re: Cognition Health (Fairfax)
8316 Arlington Blvd Suite 420, Fairfax, VA 22031

Learn More

ALZHEIMER'S DISEASE STUDY

New York

COLUMBIA
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER

The FIRST EVER Anti-Viral Clinical Trial for Alzheimer’s Disease

This research is funded by the National Institutes of Health (NIH)

Viruses may cause or contribute to the pathology of Alzheimer’s disease. This research treatment study at the MEMORY DISORDERS CLINIC is the first-ever clinical trial to address this hypothesis.

This study includes:
- Brain imaging
- Clinical assessments
- Anti-viral research treatment with pills

CONTACT US:

Columbia University Medical Center- Geriatric Psychiatry
40 Haven Avenue New York, NY 10032

Learn More

ALZHEIMER'S DISEASE STUDY

Miami

Have you started noticing changes in your memory or ability to think clearly?

A Clinical Research Study for Early Symptomatic Alzheimer’s Disease

The persons depicted in this advertisement are models and the images are being used for illustrative purposes only.

If you are experiencing memory loss or challenges performing complex tasks, you may qualify for a clinical research study for early symptomatic Alzheimer’s disease.

In order to qualify you must:
• Be 60 to 85 years old
• Have memory loss that has gotten worse over time
• Have a study partner who knows you and is willing to attend visits with you throughout the study

*The study partner must be able to speak about the participant’s day to day routines and any changes with the research staff throughout the study.

All study related care will be provided at no cost to you.
Health insurance is not required.

Ask your doctor about the TRAILBLAZER-ALZ 2 Clinical Research Study today and visit or call

When it comes to questions about your health, you’ve always sought out the answers. Why stop now?

TRAILBLAZER-ALZ 2

Learn More

ALZHEIMER'S DISEASE STUDY

Irvine

IS ALZHEIMER'S DISEASE IMPACTING YOUR ABILITY TO THINK CLEARLY?

A clinical research study of an investigational medication is being conducted for volunteers who suffer from mild cognitive impairment or mild dementia due to Alzheimer's disease

QUALIFIED PARTICIPANTS MUST:
- Be 50-80 years old
- Have mild cognitive impairment or mild dementia due to Alzheimer's Disease

QUALIFIED PARTICIPANTS MAY RECEIVE:
- Study medications & examinations at no cost
- Compensation provided for time and travel

Learn More

ALZHEIMER'S DISEASE STUDY

Lake City

AGITATION ASSOCIATED WITH
ALZHEIMER'S

Join a clinical research study!

We are seeking caregivers and those they provide care to that suffer with Agitation Associated with Alzheimer’s.

This study is at no cost to you. No insurance required and you may receive compensation for your time and travel.

Multi-Specialty Research Associates
Working today with the treatments of tomorrow
4551 West US 90 Suite 101, Lake City, FL 32055

All Multi-Specialty Research Associates studies meet applicable FDA guidelines.

Learn More